Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders
Phosphodiesterase (PDE) enzymes regulate intracellular signaling pathways crucial for brain development and the pathophysiology of neurological disorders. Among the 11 PDE subtypes, PDE4 and PDE5 are particularly significant due to their regulation of cyclic adenosine monophosphate (cAMP) and cyclic...
Saved in:
Main Authors: | Min Kyu Park, Hyun Wook Yang, Seo Young Woo, Dong Yeon Kim, Dae-Soon Son, Bo Young Choi, Sang Won Suh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/14/2/86 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Haploinsufficiency of PDE2A causes in mice increased exploratory behavior associated with upregulation of neural nitric oxide synthase in the striatum
by: Ana Gabriela de Oliveira do Rêgo, et al.
Published: (2025-02-01) -
Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology
by: Elena Carmona-Rocha, et al.
Published: (2025-01-01) -
Phosphodiesterase Type 5 Inhibitors in Male Reproduction: Molecular Mechanisms and Clinical Implications for Fertility Management
by: Aris Kaltsas, et al.
Published: (2025-01-01) -
The role of phosphodiesterase 4B in IL-8/LTB4-induced human neutrophil chemotaxis evaluated with a phosphodiesterase 4B inhibitor
by: Suzuki Osamu, et al.
Published: (2015-06-01) -
Future perspectives for PDE5 inhibitors bridging the gap between cardiovascular health and psychological status
by: Andrea Sansone, et al.
Published: (2025-01-01)